Crystals of a novel organic-inorganic hybrid compound with the structural formula (C9H17N2)2[ZnCl4] named Bis(1,8-diazabicyclo[5.4.0]undec‑7-enium) tetrachloridozincate (II), were generated and carefully investigated. The compound was comprehensively characterized through X-ray diffraction analysis under ambient conditions, differential scanning calorimetry, thermogravimetric analysis, infrared spectroscopy, nuclear magnetic resonance (NMR) spectroscopy, and optical absorption spectroscopy to evaluate its structural, thermal, vibrational, and electronic properties. X-ray diffraction showed that the compound has a monoclinic crystal structure and belongs to the P21/n space group. An infrared spectra analysis was conducted to identify the key vibration modes and their assignments. Optical analysis showed a direct allowed band gap of 4.54 eV, confirming the semiconductor nature of this hybrid material. Density functional theory (DFT) calculations were performed, followed by an analysis of the molecular electrostatic potential surface and Mulliken charge distribution. The TGA and DSC analyses confirmed the thermal stability at 340 °C, then gradually decomposes until 541 °C, releasing different compounds. A phase transition was also seen at 85 °C in the DSC curve. This study shows that DBU-Zn has dose-dependent anti-inflammatory effects, with the best result at 40mg/kg, reducing inflammation by 39%. It also has strong pain-relieving effects, lowering writhing episodes by 25% in the early phase and 61% in the late phase.
扫码关注我们
求助内容:
应助结果提醒方式:
